THIS MEETING HAS BEEN ACCREDITED WITH 5 CPD POINTS
Welcome to the UK Clinical Vaccine Network Conference 2019, a single day conference focusing on the future direction and challenges within the vaccine arena, and set to be the go-to annual conference for all those interested in vaccine development and use. The aim of the conference is to showcase the work of the UK clinical vaccine community and will be open to anyone who wants to learn more about vaccines. Topics covered will range from correlates of protection, adjuvants and novel delivery and AMR, through to global vaccines and vaccine acceptance. As part of the event we will also be holding a masterclass session for trainees and will have a plenary speaker talking about careers in vaccinology………..so something for everyone! The inaugural Clinical Vaccine Network Conference will this year be held at the beautiful Wolfson College in Oxford, a fantastic location within the UK, currently a hive of vaccine research. A hot topic within the vaccine community is that vaccines may help slow down the development of antimicrobial resistance and offer solutions for those infections with limited antibiotic options. The UK Review on AMR recognised vaccines as a priority area and has highlighted the need to increase uptake of current vaccines and to develop new vaccines. Last month alone, the Department of Health and Social Care awarded £1 million to accelerate development of bacterial vaccines to tackle AMR. The conference has been established to showcase UK vaccine research such as this and will generate discussion on future research directions. So please register and join us in what promises to be the first of many exciting vaccine conferences. We look forward to welcoming you to the UK Clinical Vaccine Network Conference 2019!
Professor Slack is an Independent Consultant Medical Microbiologist. She was formerly employed by Public Health England (PHE) as Consultant Medical Microbiologist and Head of the Haemophilus Reference Unit in the Respiratory & Vaccine Preventable Bacteria Reference Unit, Colindale, London, United Kingdom. She coordinated the laboratory aspects of enhanced population-based surveillance on invasive H. influenzae and pneumococcal disease in England and Wales. From 1975 to 2003 she was the University Lecturer (Honorary Consultant) in Bacteriology at the University of Oxford, being responsible for clinical microbiology teaching to Oxford Clinical Medical Students.
She was formerly Head of the WHO Collaborating Centre for Haemophilus influenzae and Head of the Global Reference Laboratory for H. influenzae in the WHO Global Vaccine-Preventable Invasive Bacterial Disease (VP-IBD) Surveillance Network. She has worked extensively in developing countries- assisting WHO, PATH, IVI, Hib Initiative and PneumoADIP by providing technical support, advice and training for sentinel site surveillance of paediatric bacterial meningitis, pneumonia and sepsis. Her principal research interests include the epidemiology of invasive haemophilus and pneumococcal infections and the impact of Hib and pneumococcal conjugate vaccines. Her findings in these areas have been widely published and presented at national and international meetings.